District Court Denies Blue Coat's Motion to Stay in Finjan

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
District Court Denies Blue Coat's Motion to Stay in Finjan v. Blue Coat II

EAST PALO ALTO, CA--(Marketwired - Jul 26, 2016) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, provided an update in Finjan, Inc. v. Blue Coat Systems, Inc II (5:13-cv-03295-BLF, "Blue Coat II"), with the Honorable Beth Labson Freeman presiding. On July 15, 2015, Finjan filed this second case against Blue Coat, accusing Blue Coat of further infringing ten Finjan patents. Blue Coat moved to stay Blue Coat II pending proceedings before the U.S. Patent and Trademark Office ("USPTO") and the Patent Trial and Appeal Board ("PTAB"). Today, the Court's "Order Denying Blue Coat's Motion to Stay Proceedings Pending Final Resolutions of Finjan 1 or Inter Partes Reviews and Ex Parte Rexaminations" (Doc. 67) was decided in Finjan's favor.

Blue Coat has filed 9 IPRs and 2 reexams against 6 of 10 Finjan patents in this case. To date, the USPTO and PTAB have decided against institution of 6 of the challenges; four IPR challenges were instituted (consolidated to three), and one reexamination are pending. Weighing heavily in the Court's decision, Blue Coat was not the originator of any of the three instituted IPR petitions but rather piggybacked on the filings of others. To date, he remaining seven patents asserted in the second case are not subject to any patent office proceeding.

Finjan has pending infringement lawsuits against FireEye, Inc., Sophos, Inc., Symantec Corp., Palo Alto Networks, Inc., ESET and its affiliates relating to, collectively, more than 20 patents in the Finjan portfolio. The court dockets for the foregoing cases are publicly available on the Public Access to Court Electronic Records (PACER) website, www.pacer.gov, which is operated by the Administrative Office of the U.S. Courts.

ABOUT FINJAN
Established 20 years ago, Finjan is a globally recognized leader in cybersecurity. Finjan's inventions are embedded within a strong portfolio of patents focusing on software and hardware technologies capable of proactively detecting previously unknown and emerging threats on a real-time, behavior-based basis. Finjan continues to grow through investments in innovation, strategic acquisitions, and partnerships promoting economic advancement and job creation. For more information, please visit www.finjan.com.

Follow Finjan Holdings, Inc.:
Twitter: @FinjanHoldings
LinkedIn: linkedin.com/company/finjan

Cautionary Note Regarding Forward-Looking Statements
Except for historical information, the matters set forth herein that are forward-looking statements involve certain risks and uncertainties that could cause actual results to differ. Potential risks and uncertainties include, but are not limited to, Finjan's expectations and beliefs regarding Finjan's licensing program, the outcome of pending or future enforcement actions, the granting of Inter Partes Review (IPR) of our patents or an unfavorable determination pursuant to an IPR or other challenges at the USPTO of our patents, the enforceability of our patents, the cost of litigation, the unpredictability of our cash flows, our ability to expand our technology and patent portfolio, the continued use of our technologies in the market, our stock price, changes in the trading market for our securities, regulatory developments, general economic and market conditions, the market acceptance and successful business, technical and economic implementation of Finjan Holdings' intended operational plan; and the other risk factors set forth from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the year ended December 31, 2015, and the Company's periodic filings with the SEC, copies of which are available free of charge at the SEC's website at www.sec.gov or upon request from Finjan Holdings, Inc. All forward-looking statements herein reflect our opinions only as of the date of this release. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Finjan Holdings undertakes no obligation, and expressly disclaims any obligation, to update forward-looking statements herein in light of new information or future events.

Investor Contact:
Vanessa Winter
Finjan Holdings, Inc.
Capital Markets Group LLC
(650) 282-3245
investors@finjan.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action: Key Details for Investors

Updated Category News Views 328

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 233

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 284

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 492

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 487

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 236

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 378

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 366

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 445

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 409

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading

Top 5 Most Recently Viewed Articles

JSA Welcomes New Advisory Board Members in AI and Sustainability

Updated Category News Views 114

Expanding the Advisory Board at JSA JSA, a leading marketing agency dedicated to the digital infrastructure sector, has announced significant additions to its Advisory Board, welcoming two highly esteemed professionals, Bill Kleyman and Melissa Farney. These new members bring extensive expertise in sustainability and artificial intelligence, enhancing JSA's ability to...

Continue Reading
Eurobank's Successful EUR 600 Million Bond Sale Announcement

Updated Category News Views 175

Eurobank Achieves Milestone with EUR 600 Million Bond Sale Eurobank SA has recently marked a significant achievement by successfully selling EUR 600 million in callable senior preferred securities. This success is underlined by the absence of stabilisation actions, indicating a robust market demand for this financial instrument. Details of the Bond Offering According to...

Continue Reading
KBR Takes Charge of Major Fertilizer Project in Angola

Updated Category News Views 207

KBR Takes Charge of Major Fertilizer Project KBR (NYSE: KBR) has recently embarked on a significant venture by securing a contract for Project Management Consultancy (PMC) services that will support the development of a crucial fertilizer plant. This project, commissioned by AMUFERT, is pivotal in enhancing fertilizer production capacity. About the Fertilizer Project The...

Continue Reading
Revitalizing Lawn Care with Sunseeker's Elite X9 Series

Updated Category News Views 181

Revolutionizing Lawn Maintenance with Elite Technology At the forefront of innovation, Sunseeker is making headlines with its newest breakthrough, the Sunseeker Elite X9 Series. Advanced Mowing Capabilities Positioned to transform the landscaping industry, the Elite X9 Series robotic mowers operate effectively in demanding commercial environments. With the capacity to...

Continue Reading
Dr. Rajan Bhatt Takes Charge as New CEO of OrthoArizona

Updated Category News Views 1074

Dr. Rajan Bhatt Appointed as CEO of OrthoArizona OrthoArizona, recognized as one of the largest privately held orthopedic organizations in the nation, has recently named Dr. Rajan Bhatt as their new Chief Executive Officer. Dr. Bhatt is not only a renowned physician but also an entrepreneur with extensive business expertise, making him an ideal candidate for orchestrating...

Continue Reading